Bulk drugs and drug intermediates accounted for about 53% of India's total pharmaceutical imports in fiscal year 2020. India is highly dependent on imports for its drug intermediates and bulk drugs, sourcing over 60% from other countries, with over 65% coming from China alone. There are two main types of drug intermediates: advanced intermediates and active pharmaceutical ingredients (APIs), which are precursor materials used to produce finished drug formulations for therapeutic effects.